GET A QUOTE

KIM-1 ELISA Kit (Kidney Injury Molecule 1)

INTENDED USE

Human KIM-1 ELISA kit can be used for detecting in vitro quantitative levels of kidney injury molecule 1 (KIM1) in human serum, plasma, biological fluids and tissue homogenates. This assay has a minimum detection limit of 0.94ng/ml.

BACKGROUND

Kidney injury molecule 1 (KIM-1, KIM1) is also called hepatitis A virus cellular receptor 1, it is a transmembrane glycoprotein which is 339 amino acid in length where the N-terminal ectodomain contains the mucin and immunoglobulin-like domains. It normally exists in very low levels in normal kidneys, however when upregulated during injury, it is detectable in urine in a number of different human diseases.

Several new early biomarkers of acute kidney injury (AKI) have indicated KIM-1 among the most promising ones. It has not only been discovered as a sensitive diagnostic marker but also a predictive value for AKI in patients who are undergoing cardiac surgery. It has been identified as a potential biomarker for renal injury, acute kidney failure or acute tubular necrosis and it has a great importance in many kidney disorders and diseases.

CONTENT


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • One 96-Well Plate: Pre-coated with anti-KIM1 antibody.
  • Standards: Concentrations 0, 0.156, 0.312, 0.625, 1.25, 2.5, 5.0, 10.0 ng/ml, made up from lyophilized recombinant.
  • Sample/Standard Dilution Buffer.
  • Biotinylated-Labelled Antibody.
  • Antibody Dilution Buffer.
  • HRP-Streptavidin Conjugate (SABC).
  • SABC Dilution Buffer.
  • TMB Substrate.
  • Wash Buffer (25x).
  • Plate Sealer.
  • Product Instructions.

SENSITIVITY

The minimum detection sensitivity level of kidney injury molecule 1 (KIM1) using this KIM-1 ELISA kit was 0.194 ng/ml. The dynamic range for this assay is 0.156 – 10 ng/ml.

ASSAY CHARACTERISTICS

– Specificity: Highly specific for KIM1, no cross reactivity or interference between KIM1 and analogues was detected.
– Recovery: Serum (86 – 102%), EDTA Plasma (86 – 104%), Heparin Plasma (88 – 105%).
– Linearity: Serum (88 – 105%), EDTA Plasma (86 – 98%), Heparin Plasma (87 – 100%).
– Precison Intra-Assay: CV < 8%.
– Precison Inter-Assay: CV < 10%.
– Stability: Less than 10%.

REFERENCES

  1. Molecular markers of kidney injury. Urol Oncol. (2013) 31 (5): 682-5. Review. Lane B.R.
  2. Kidney injury molecule-1 in kidney disease. Ren Fail. (2016) 38 (10): 1567-1573. Yin C. and Wang N.
  3. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. (2013) 28 (2): 254-73. Review. Vanmassenhove J., et al.
  4. Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. Biomed Res Int. (2014) 2014: 602526. Review. Mussap M., et al.

ADDITIONAL INFORMATION

  • Full Name: KIM-1 ELISA Kit (Kidney Injury Molecule 1)
  • Reactivity: Human
  • Sample Type: Serum, Biological Fluids , Plasma, Tissue Homogenates
  • Sensitivity: 0.195 ng/ml

OTHER RELATED ELISA KITS

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford